+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
From
From
Piroxicam Capsules Market - Global Forecast 2025-2030 - Product Thumbnail Image

Piroxicam Capsules Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
Triamcinolone Tablets Market - Global Forecast to 2030 - Product Thumbnail Image

Triamcinolone Tablets Market - Global Forecast to 2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Piroxicam Patches Market - Global Forecast 2025-2030 - Product Thumbnail Image

Piroxicam Patches Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Kallikrein Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

Kallikrein Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Minocycline Hydrochloride Market - Global Forecast 2025-2030 - Product Thumbnail Image

Minocycline Hydrochloride Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
From
Periodic Fever Syndrome - Global Strategic Business Report - Product Thumbnail Image

Periodic Fever Syndrome - Global Strategic Business Report

  • Report
  • October 2025
  • 390 Pages
  • Global
From
Nasal Corticosteroids - Global Strategic Business Report - Product Thumbnail Image

Nasal Corticosteroids - Global Strategic Business Report

  • Report
  • October 2025
  • 469 Pages
  • Global
From
Triamcinolone - Global Strategic Business Report - Product Thumbnail Image

Triamcinolone - Global Strategic Business Report

  • Report
  • October 2025
  • 378 Pages
  • Global
From
Ibuprofen API - Global Strategic Business Report - Product Thumbnail Image

Ibuprofen API - Global Strategic Business Report

  • Report
  • October 2025
  • 139 Pages
  • Global
From
Hydroxychloroquine - Global Strategic Business Report - Product Thumbnail Image

Hydroxychloroquine - Global Strategic Business Report

  • Report
  • October 2025
  • 293 Pages
  • Global
From
From
Uveitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Uveitis Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 413 Pages
  • Global
From
From
Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 182 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more